Back to search
Hemangioblastoma of CNS
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemangioblastoma of CNS trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemangioblastoma of CNS trials you may qualify forEvery new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in n…
The study population consists of patients who undergo resection for somatostatin receptor-positive (SSTR-positive) CNS tumors, focusing on meningioma, and inclu…
The BELIEVE-VHL Trial is a prospective real-life study designed to evaluate the therapeutic effects, benefits, and adverse effects of belzutifan, as well as the…
The aim of the Phase Ia portion is to identify the maximum tolerated dose or maximum acceptable dose MTD/MAD of HS-10516. The phase Ib portion will evaluate the…
Propranolol (beta-blocker), is successfully used for the treatment of infantile hemangiomas, the most common vascular tumor of newborns. The mechanism is relate…
The purpose of this study is to learn more about the growth of brain and spinal cord tumors and cysts that develop in association with them in patients with von…
This is a prospective observational cohort study evaluating the effectiveness and safety of belzutifan treatment in routine clinical practice. This study has b…
Von Hippel-Lindau (VHL) disease is a severe autosomal dominant genetic disorder (with almost complete penetrance) that predisposes to many tumors including some…